Series C funding round for Vyome Therapeutics raising $14M in August 2016
Series C funding round for Vyome Therapeutics raising $14M in August 2016
| Investor | Firm Type | Partner |
|---|
Romulus CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Arash Ferdowsi | |
| Angel | Drew Houston | |
| Angel | Oren Yunger | |
| Angel | Alice Lloyd George | |
| Angel | George Hu |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$79M
Top Valuation
-
Vyome Therapeutics raised $14M in a Series C round.
The round was announced on 08/01/16.
The round was led by Perceptive Advisors, Romulus Capital.